Hepatitis E in Southeast Asia

Paul Wasuwanich, Supharerk Thawillarp, Thammasin Ingviya, Wikrom Karnsakul

Research output: Contribution to journalArticlepeer-review

Abstract

Hepatitis E is a major cause of acute viral hepatitis in the world. The causative agent of hepatitis E is hepatitis E virus (HEV). In Southeast Asia, the seroprevalence of HEV and the most prevalent genotype of HEV are largely unclear and the available data is either limited or outdated. After a systematic review of literature, we found the seroprevalence of HEV and the most prevalent genotype of HEV appear to vary greatly by countries. The seroprevalence is likely between 17% to 42% and the prevalent genotypes across Southeast Asia are likely 1, 3, and 4, but not 2 as no cases of genotype 2 have been reported in this region. As HEV remains widespread in Southeast Asia and the clinical implications of HEV can be severe, surveillance programs for HEV should be implemented.

Original languageEnglish (US)
Pages (from-to)259-264
Number of pages6
JournalSiriraj Medical Journal
Volume72
Issue number3
DOIs
StatePublished - May 1 2020

Keywords

  • Epidemiology
  • Genotype
  • Seroepidemiologic studies
  • Swine
  • Vaccination

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hepatitis E in Southeast Asia'. Together they form a unique fingerprint.

Cite this